Ivosidenib
Sources
publication, as of 2026-11-07
https://ascopubs.org/doi/10.1200/JCO.19.03327
Mellinghoff IK et al. Ivosidenib in IDH1-mutated advanced glioma. J Clin Oncol 2020;38:3398-3406 (NCT02073994; abstract)
Brief source I11
registry, as of 2026-11-07
https://clinicaltrials.gov/study/NCT02073994
A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
ClinicalTrials.gov API v2 record, retrieved 2026-11-07